Late rectal symptoms and quality of life after conformal radiation therapy for prostate cancer

被引:31
作者
Geinitz, Hans
Zimmermann, Frank B.
Thamm, Reinhard
Erber, Caroline
Mueller, Tobias
Keller, Monika
Busch, Raymonde
Molls, Michael
机构
[1] Tech Univ Munich, Dept Radiat Oncol, D-81675 Munich, Germany
[2] Univ Hosp Heidelberg, Dept Psychophysiol, Heidelberg, Germany
[3] Tech Univ Munich, Inst Med State & Epidemiol, Munich, Germany
关键词
prostate cancer; conformal radiation therapy; rectal toxicity; fecal continence; quality of life;
D O I
10.1016/j.radonc.2006.05.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: This study was carried out in order to analyze the prevalence of late rectal and anal symptoms after conformal radiation therapy for prostate cancer and to assess their association with quality of life. Patients and methods: Two-hundred and forty nine patients were interviewed at 24-111 months after definitive conformal radiation therapy of localized prostate cancer with a median dose of 70 Gy. Rectal symptoms and fecal incontinence were evaluated with standardized questionnaires. Quality of life was assessed with the EORTC Quality of Life Questionnaire-C30 and the prostate cancer module PR25. Results: Rectal symptoms were mostly intermittent. Daily symptoms occurred in <= 5% of the patients. Incontinence was mostly mild with only 3% of the patients reporting daily incontinence episodes. Quality of life was comparable to that of the male German general population except that cognitive functioning and diarrhea were worse in the study population and pain was worse in the reference population. Global quality of life was associated with fecal incontinence, fecal urge, tenesmus, therapy for rectal symptoms and hormonal therapy for biochemical/clinical recurrence. Conclusions: Rectal symptoms and fecal incontinence after conformal radiation therapy for prostate cancer are mostly intermittent. Fecal incontinence, fecal urge and tenesmus are associated with lower global quality of life levels. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:341 / 347
页数:7
相关论文
共 41 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum [J].
Al-Abany, M ;
Helgason, AR ;
Cronqvist, AKA ;
Lind, B ;
Mavroidis, P ;
Wersäll, P ;
Lind, H ;
Qvanta, E ;
Steineck, G .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (04) :1035-1044
[3]  
[Anonymous], 1997, Int J Radiat Oncol Biol Phys, V37, P1035
[4]   The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer [J].
Bacon, CG ;
Giovannucci, E ;
Testa, M ;
Kawachi, I .
JOURNAL OF UROLOGY, 2001, 166 (05) :1804-1810
[5]   Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: A prospective multiinstitutional outcomes study [J].
Beard, CJ ;
Propert, KJ ;
Rieker, PP ;
Clark, JA ;
Kaplan, I ;
Kantoff, PW ;
Talcott, JA .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) :223-229
[6]   Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms [J].
Boersma, LJ ;
van den Brink, M ;
Bruce, AM ;
Shouman, T ;
Gras, L ;
te Velde, A ;
Lebesque, JV .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (01) :83-92
[7]   Delayed rectal and urinary symptomatotogy in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation [J].
Christie, D ;
Denham, J ;
Steigler, A ;
Lamb, D ;
Turner, S ;
Mameghan, H ;
Joseph, D ;
Matthews, J ;
Franklin, I ;
Atkinson, C ;
North, J ;
Poulsen, M ;
Spry, NA ;
Tai, KH ;
Wynne, C ;
Duchesne, G ;
Kovacev, O ;
Francis, L ;
Kramar, A ;
D'Este, C ;
Bill, D .
RADIOTHERAPY AND ONCOLOGY, 2005, 77 (02) :117-125
[8]   Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: The patient's perspective [J].
Crook, J ;
Esche, B ;
Futter, N .
UROLOGY, 1996, 47 (03) :387-394
[9]   Dose-volume histograms associated to long-term colorectal functions in patients receiving pelvic radiotherapy [J].
Fokdal, L ;
Honoré, H ;
Hoyer, M ;
von der Maase, H .
RADIOTHERAPY AND ONCOLOGY, 2005, 74 (02) :203-210
[10]  
Fransson P, 2001, CANCER-AM CANCER SOC, V92, P3111, DOI 10.1002/1097-0142(20011215)92:12<3111::AID-CNCR10160>3.0.CO